A couple married for 3 years, the woman repeated abortion 3 times, the karyotype analysis of the couple showed no abnormality. Advised by the doctor, they tried preimplantation genetic testing for aneuploidy (PGT-A) and get 3 embryos, technicians found that there are two blastocysts without abnormal chromosomes. After comprehensive evaluation, the doctor finally selected Emb1 embryo for implantation. Now this woman is successful pregnant and all test indexes are good.
Preimplantation Genetic Testing For Aneuploidies
BasePGT-A is primarily used to detect whether there is chromosomal aneuploidy in embryo, so as to improve pregnancy and live birth rates. Chromosomal aneuploidy is the main cause of IVF failure and miscarriage. With single cell amplification technology and high-throughput sequencing technology, PGT-A is a technique to detect all 23 pairs of chromosomes of cleavage or blastocyst stage embryos created in the assisted reproductive process to select embryos with normal chromosomes for implantation, thus to improve the clinical pregnancy rate and reduce the abortion rate of IVF.
Men with Severe teratospermia
Pregnant women who at an advanced age (≥35 years old)
Pregnant women who experience spontaneous abortions (≥2 times) with unknown reasons
Pregnant women who experience repeated implant failure (≥3 times) for unknown reasons (implanted 4-6 high grading cleavage stage embryos or blastocyst embryos for more than 3 times are all failed)
The first PGT-A kit approved by CFDA (Approval No. 20203400181)
Increase pregnancy rate to 72%, decrease miscarriage rate to 6.9%
Screen aneuploidy of full 23 pairs chromosomes at a time
High resolution for new recurring chromosome abnormality (≥4M)
Up to 200,000 yuan health insurance to protect patients interests
Well-established quality control system, rich experience in embryo detection